Clinical Trials Logo

Intestinal Diseases clinical trials

View clinical trials related to Intestinal Diseases.

Filter by:

NCT ID: NCT04293653 Active, not recruiting - Frailty Clinical Trials

Protocol for Patients Above 75 Years Undergoing Emergency Laparotomy

(ProPEL)
Start date: January 21, 2020
Phase: N/A
Study type: Interventional

In the ProPEL study the effect of a protocol designed for elderly patients about to undergo emergency abdominal surgery will be investigated. The protocol addresses issues of both frailty and ceiling-of -care decisions.

NCT ID: NCT04291976 Completed - Clinical trials for Inflammatory Bowel Diseases

Back-to-back Endoscopy Versus Single-pass Endoscopy and Chromoendoscopy in IBD Surveillance

HELIOS
Start date: March 13, 2020
Phase: N/A
Study type: Interventional

The current international guidelines for CRC surveillance in IBD recommend as first choice the use of chromoendoscopy, and as an alternative high-definition white light endoscopy (HDWLE) for optimal dysplasia detection, based on data from clinical trials. However, data on the superiority of CE over HDWLE are not consistent in literature. The investigators hypothesize that the better performance of CE in some clinical trials is the result of the associated longer procedural time and the fact that every colon segment is examined twice. Currently, no studies have been published evaluating the dysplastic yield of back-to back HDWLE compared to HDWLE with a single pass or CE in patients with IBD. In the present study, the investigators aim to compare the yield of dysplasia/CRC between 1) regular HDWLE, 2) HDWLE back-to-back, and 3) CE.

NCT ID: NCT04290156 Not yet recruiting - Ulcerative Colitis Clinical Trials

The Effect of Joint Transition Visits on Quality of Life in Inflammatory Bowel Diseases (TRANS-IBD)

TRANS-IBD
Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Inflammatory bowel diseases (IBD) are among the most common chronic illnesses diagnosed in childhood. Moving from the pediatric to the adult health care is a crucial phase, which can greatly affect adolescents' quality of life. According to the latest international guidelines, based in particular on expert opinions, the implementation of joint visits (involving both pediatric and adult gastroenterologists) are highly recommended during the transition period. This trial aims to prove the beneficial effect of the joint visits.

NCT ID: NCT04288882 Not yet recruiting - Role of Enteroscopy Clinical Trials

Role of Balloon-Assisted Enteroscopy (BAE) in Small Intestinal Disorders

Start date: March 2020
Phase:
Study type: Observational

Overall Aim: This study is designed to assess the role of ballon-assisted enteroscopy in the management of obscure small intestinal disorders in a tertiary-care center in Upper Eygpt. Specific objectives: 1. Evaluate the technical success rate and causes of the procedure in our locality 2. Explore the value and safety of BAE in the diagnose and treatment of suspected small bowel diseases. 3. Assess patients' and endoscopists' satisfaction related to the procedure. 4. Define the indications, diagnostic yield and appropriatness of BAE in our center. 5. Determine the value of enteroscopy-obtained biopsy samples in the diagnosis. 6. Perform a cost analysis of BAE in relation to its diagnostic value/yield. 7. Report the therapeutic role of BAE in different small intestinal disorders.

NCT ID: NCT04286659 Not yet recruiting - Clinical trials for Inflammatory Bowel Diseases

Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease

Start date: March 1, 2020
Phase:
Study type: Observational

The inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal tract that manifests as Crohn's disease (CD) and Ulcerative colitis (UC . Over the last two decades the incidence pattern of UC showed significant increase in previously low incidence areas such as Asia and the Middle East. In addition to microbial and environmental factors influencing IBDs, they are complex genetically, where hundreds of genetic loci contribute to disease susceptibility . Genome-wide association studies (GWAS) have identified several genetic susceptibility loci for UC and CD. Among the genetic factors involved, there are several single nucleotide polymorphisms (SNP) in molecules of the immune system associated with either susceptibility or protective effects to IBD progression, but with contradictory associations, mainly depending on the onset (adult or pediatric), sample size differences, inadequate statistical power and on the ethnicity-dependent genetic background. Growing evidence indicates that (RAGE) is involved in chronic inflammation and cancer. It is a transmembrane receptor normally expressed at low levels on a wide range of cells, bind a broad spectrum of ligands. Activated RAGE induces the synthesis of proinflammatory molecules resulting in magnifying rather than dampening inflammation . The human RAGE gene is located on chromosome 6p21.3, in the so-called class III of the major histocompatibility complex. The SNP at the -374A/T and -429T/C of the promoter region have been shown to increase protein synthesis threefold and twofold, respectively. Few studies found that RAGE is up-regulated in IBD, and it appears to play a role in the mechanisms involved in chronic inflammation Little information is available on the possible association of such polymorphisms with IBD. Few studies was carried out in different countries to assess these polymorphisms in IBD, resulting in conflicting results, between supporting and denial of the association. Due to this discrepancy we aimed to study this gene in our community including IBD patients.

NCT ID: NCT04284878 Not yet recruiting - Clinical trials for Inflammatory Bowel Diseases

Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease

Start date: May 1, 2020
Phase:
Study type: Observational

This study aims: 1. To investigate the association between single nucleotide polymorphisms of PTPN22 gene (rs2476601, rs33996649 and rs2488457) and inflammatory bowel disease. 2. To correlate the relation between the studied SNPs and disease activity /response to therapy.

NCT ID: NCT04282577 Not yet recruiting - Clinical trials for Inflammatory Bowel Diseases

Urinary Biomarkers of Renal Injury in Inflammatory Bowel Disease

Start date: March 1, 2020
Phase:
Study type: Observational

The study aims to early detection of renal injury in patients diagnosed to have inflammatory bowel disease with normal kidney function test focusing on glomerular filtration barrier injury and tubular injury and it's relation to disease activity so precautions could be taken properly to prevent further renal injury later on .

NCT ID: NCT04280510 Recruiting - Clinical trials for Inflammatory Bowel Diseases

Pathogenic Study of Adult Immune Enteropathies

ENTEROPAH
Start date: February 27, 2020
Phase:
Study type: Observational

The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.

NCT ID: NCT04272307 Recruiting - Clinical trials for Inflammatory Bowel Diseases

MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.

ITAC
Start date: May 14, 2020
Phase:
Study type: Observational

This pilot prospective study will investigate the role of microbiota and known enteropathogens in Acute Severe Ulcerative Colitis (ASUC). Investigators will compare a group of patients hospitalized for an ASUC with patients experiencing a Non-Severe Ulcerative Colitis (NSUC) flare by investigating microbiome, metabolome and transcriptome and integrating this data through a multi-omic framework. This systems biology approach aims at enhance our understanding of this severe event, define diagnosis and prognosis biomarkers to improve medical therapy and avoid colectomy and/or death.

NCT ID: NCT04263818 Completed - Colonic Diseases Clinical Trials

Endoscopist and Endoscope Motions During Colonoscopy

ScopeGuide
Start date: June 5, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to record and analyze endoscopist and endoscope motions to identify key movements during colonoscopy.